Anti-thrombotic trials in atrial fibrillation, the RELY study.
J
J
Aalbers
D000925:Anticoagulants / Q000627:therapeutic use*; D058833:Antithrombin Proteins / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000069604:Dabigatran; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D012107:Research Design; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
D000925:Anticoagulants; D058833:Antithrombin Proteins; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran